Balloon Pulmonary Angioplasty (BPA) ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
88	慢性血栓塞栓性肺高血圧症	2

88. 慢性血栓塞栓性肺高血圧症

---

臨床試験数 : 159 /  薬物数 : 118 - (DrugBank : 23) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 53

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCTs041200052	30/06/2021	22/10/2020	THERAPY-HYBRID-BPA trial	The Effect of Riociguat for Peak Cardiac Index on Cardiopulmonary Exercise Test in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Patients after Normalization of Pulmonary Artery Pressure by Combination Treatment of Riociguat and Balloon Pulmonary Angioplasty. - Riociguat-CTEPH	chronic thromboembolic pulmonary hypertension CTEPH;D000081029	In this study, we will perform continuous verification by allocating the Chronic Thromboembolic Pulmonary Hypertension (CTEPH) patients whose hemodynamics were normalized after Balloon Pulmonary Angioplasty (BPA) to the the riociguat active group and placebo group for 16 weeks.	Shimokawahara Hiroto	NULL	Recruiting	>= 18age old	< 85age old	Both	72	Phase 2	Japan
2	NCT02634203 (ClinicalTrials.gov)	January 19, 2016	8/12/2015	Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension	Riociguat Versus Balloon Pulmonary Angioplasty in Non-operable Chronic thromboEmbolic Pulmonary Hypertension	Chronic Thromboembolic Pulmonary Hypertension	Procedure: Balloon Pulmonary Angioplasty (BPA);Drug: Riociguat	Assistance Publique - Hôpitaux de Paris	Bayer	Completed	18 Years	80 Years	All	105	N/A	France